相关实验视频
Updated: Jul 15, 2026
07:58
Nephrotoxin Microinjection in Zebrafish to Model Acute Kidney Injury
Published on: July 17, 2016
在急性损伤中识别可用药物的目标,采用蛋白质和转录基因组范围的门德尔随机化和生物信息学分析
Jiachen Liu1,2, Dianjie Zeng1,3,4, Yinhuai Wang1
1Department of Urology, The Second Xiangya Hospital at Central South University, Changsha, 410011, Hunan, China.
Biology direct
|March 28, 2025
概括
这项研究确定了与急性损伤 (AKI) 风险相关的关键基因和蛋白质. 研究结果表明,针对针对性AKI治疗的新药重定向策略.
科学领域:
- 基因组学和生物信息学
- 腎臟病學 (nephrology) 是一種醫學專業.
- 药理学 药理学是指药理学的学科.
背景情况:
- 急性损伤 (AKI) 是一种严重的疾病,治疗选择有限.
- 目前的治疗主要依赖于置换疗法.
- 开发针对AKI的向疗法仍然是一个重大挑战.
研究的目的:
- 通过多学科的方法,确定AKI的新型治疗点.
- 探索现有药物用于治疗AKI的药物重用机会.
- 调查遗传因素与AKI风险之间的因果关系.
主要方法:
- 综合遗传数据 (可使用药物的蛋白质,基因表达) 与AKI全基因组关联研究 (GWAS) 的发现.
- 采用多omics门德尔随机化 (MR) 来识别因果基因和蛋白质.
- 使用反向MR,外部队列,转录组数据和分子相互作用网络验证的发现.
主要成果:
- 确定了7种蛋白质和12种与AKI风险相关的因果基因.
- 优先考虑的六个关键目标 (NCF1,TNFRSF1B,APEH,ACADSB,ADD1,FAM3B) 在独立队列中得到验证.
- 发现了潜在的药物重新定位候选者,包括telmisartan,calcitriol和ethinyl estradiol.
结论:
- 这项研究为AKI提供了有前途的治疗点.
- 强调在AKI管理中药物重新利用的重大机遇.
- 为开发新,有针对性的AKI治疗提供了洞察力.
更多相关视频
相关概念视频
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:22Acute Kidney Injury I: Introduction
Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
01:29Acute Kidney Injury II: Pathophysiology
Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
01:20Acute Kidney Injury V: Interprofessional Care
Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...